Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Isotretinoin-Associated Serum Creatinine Elevation During Acne Treatment: A Case Report.

Created on 03 Sep 2026

Authors

Yi Chen, Ye-Ping Qin, Yan Li, Jing-Peng Chen, Ren-Jie Li, Ruo-Zhou Qi, Bao-Chen Zhu, Hui-Shang Feng

Published in

Clinical, cosmetic and investigational dermatology. Volume 19. Pages 628487. Epub Aug 29, 2026.

Abstract

Isotretinoin is first-line for moderate-to-severe acne. Its common adverse reactions involve the mucocutaneous system, liver, and lipid metabolism, while renal dysfunction is often overlooked with scarce reports.
A 34-year-old female without prior renal dysfunction received isotretinoin 20 mg/day for acne. Serum creatinine rose after 3 weeks, reached 82.6 μmol/L by week 5, then decreased stepwise after discontinuation and normalized on follow-up. Urinary ultrasound was unremarkable.
The Naranjo score was 7, indicating a probable association. Unlike previous renal adverse events presenting with dysuria, edema, flank pain, or hematuria, this case was asymptomatic, which may be attributed to individual differences in drug metabolism.
This case report describes a mild elevation in serum creatinine that was possibly associated with isotretinoin therapy and highlights the importance of clinical awareness of potential renal function changes during treatment, particularly in patients receiving long-term therapy or concomitant medications.

PMID:
42689161
Bibliographic data and abstract were imported from PubMed on 03 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement